Resultados da busca - Atkinson, Victoria
- Mostrando 1 - 20 resultados de 39
- Ir para a próxima página
-
1
Case 1: Fever and a genital ulcer in a recent immigrant por Atkinson, Victoria, Swartz, Erik
Publicado em 2011Texto -
2
-
3
-
4
Tumoral melanosis associated with combined BRAF/MEK inhibition (dabrafenib/trametinib) in metastatic melanoma por Laino, Antonia, Shepherd, Benjamin, Atkinson, Victoria, Fu, Hong, Soyer, H. Peter, Schaider, Helmut
Publicado em 2018Texto -
5
Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis Secondary to Mucinous Adenocarcinoma of the Appendix por Sparks, David S., Morris, Bradley, Xu, Wen, Fulton, Jessica, Atkinson, Victoria, Meade, Brian, Lutton, Nicholas
Publicado em 2015Texto -
6
Eftilagimod alpha, a soluble lymphocyte activation gene-3 (LAG-3) protein plus pembrolizumab in patients with metastatic melanoma por Atkinson, Victoria, Khattak, Adnan, Haydon, Andrew, Eastgate, Melissa, Roy, Amitesh, Prithviraj, Prashanth, Mueller, Christian, Brignone, Chrystelle, Triebel, Frederic
Publicado em 2020Texto -
7
Dual catalytic enantioselective desymmetrization of allene-tethered cyclohexanones por Zhang, Lin, Yamazaki, Ken, Leitch, Jamie A., Manzano, Ruben, Atkinson, Victoria A. M., Hamlin, Trevor A., Dixon, Darren J.
Publicado em 2020Texto -
8
Histological diagnosis of immune checkpoint inhibitor induced acute renal injury in patients with metastatic melanoma: a retrospective case series report por Hultin, Sebastian, Nahar, Kazi, Menzies, Alexander M., Long, Georgina V., Fernando, Suran L., Atkinson, Victoria, Cebon, Jonathan, Wong, Muh Geot
Publicado em 2020Texto -
9
Protocol for implementation of the ‘AusPROM’ recommendations for elective surgery patients: a mixed-methods cohort study por Morris, Meg E, Brusco, Natasha, Woods, Jeffrey, Myles, Paul S, Hodge, Anita, Jones, Cathy, Lloyd, Damien, Rovtar, Vincent, Clifford, Amanda, Atkinson, Victoria
Publicado em 2021Texto -
10
Implementing PROMS for elective surgery patients: feasibility, response rate, degree of recovery and patient acceptability por Brusco, Natasha K., Atkinson, Victoria, Woods, Jeffrey, Myles, Paul S., Hodge, Anita, Jones, Cathy, Lloyd, Damien, Rovtar, Vincent, Clifford, Amanda M., Morris, Meg E.
Publicado em 2022Texto -
11
In-Depth Characterisation of Real-World Advanced Melanoma Patients Receiving Immunotherapies and/or Targeted Therapies: A Case Series por Sanjida, Saira, Betz-Stablein, Brigid, Atkinson, Victoria, Janda, Monika, Barsoum, Ramez, Edwards, Harrison Aljian, Chiu, Frank, Tran, My Co, Soyer, H Peter, Schaider, Helmut
Publicado em 2022Texto -
12
Patient Judgement of Change with Elective Surgery Correlates with Patient Reported Outcomes and Quality of Life por Morris, Meg E., Atkinson, Victoria, Woods, Jeffrey, Myles, Paul S., Hodge, Anita, Jones, Cathy H., Lloyd, Damien, Rovtar, Vincent, Clifford, Amanda M., Brusco, Natasha K.
Publicado em 2022Texto -
13
Human CD141(+) dendritic cells (cDC1) are impaired in patients with advanced melanoma but can be targeted to enhance anti-PD-1 in a humanized mouse model por Lee, Yoke Seng, O'Brien, Liam J, Walpole, Carina M, Pearson, Frances E, Leal-Rojas, Ingrid M, Masterman, Kelly-Anne, Atkinson, Victoria, Barbour, Andrew, Radford, Kristen J
Publicado em 2021Texto -
14
Poor Potential Coverage for 7-Valent Pneumococcal Conjugate Vaccine, Malawi por Gordon, Stephen B., Kanyanda, Stonard, Walsh, Amanda L., Goddard, Kristy, Chaponda, Mas, Atkinson, Victoria, Mulwafu, Wakisa, Molyneux, Elizabeth M., Zijlstra, Ed E., Molyneux, Malcolm E., Graham, Steve M.
Publicado em 2003Texto -
15
Acetylsalicylic Acid Governs the Effect of Sorafenib in RAS Mutant Cancers por Hammerlindl, Heinz, Menon, Dinoop Ravindran, Hammerlindl, Sabrina, Emran, Abdullah Al, Torrano, Joachim, Sproesser, Katrin, Thakkar, Divya, Xiao, Min, Atkinson, Victoria G., Gabrielli, Brian, Haass, Nikolas K., Herlyn, Meenhard, Krepler, Clemens, Schaider, Helmut
Publicado em 2017Texto -
16
Proton Pump Inhibitor Use and Efficacy of Nivolumab and Ipilimumab in Advanced Melanoma por Homicsko, Krisztian, Dummer, Reinhard, Hoeller, Christoph, Wolchok, Jedd D., Hodi, F. Stephen, Larkin, James, Ascierto, Paolo A., Atkinson, Victoria, Robert, Caroline, Postow, Michael A., Re, Sandra, Paulucci, David, Dobler, Darin, Michielin, Olivier
Publicado em 2022Texto -
17
Stereotactic radiosurgery for melanoma brain metastases: Concurrent immune checkpoint inhibitor therapy associated with superior clinicoradiological response outcomes por Shanker, Mihir D, Garimall, Sidyarth, Gatt, Nick, Foley, Heath, Crowley, Samuel, Le Cornu, Emma, Muscat, Kendall, Soon, Wei, Atkinson, Victoria, Xu, Wen, Watkins, Trevor, Huo, Michael, Foote, Matthew C, Pinkham, Mark B
Publicado em 2022Texto -
18
Pathogenic germline variants are associated with poor survival in stage III/IV melanoma patients por Aoude, Lauren G., Bonazzi, Vanessa F., Brosda, Sandra, Patel, Kalpana, Koufariotis, Lambros T., Oey, Harald, Nones, Katia, Wood, Scott, Pearson, John V., Lonie, James M., Arneil, Melissa, Atkinson, Victoria, Smithers, B. Mark, Waddell, Nicola, Barbour, Andrew P.
Publicado em 2020Texto -
19
Nivolumab for Patients With Advanced Melanoma Treated Beyond Progression: Analysis of 2 Phase 3 Clinical Trials por Long, Georgina V., Weber, Jeffrey S., Larkin, James, Atkinson, Victoria, Grob, Jean-Jacques, Schadendorf, Dirk, Dummer, Reinhard, Robert, Caroline, Márquez-Rodas, Ivan, McNeil, Catriona, Schmidt, Henrik, Briscoe, Karen, Baurain, Jean-François, Hodi, F. Stephen, Wolchok, Jedd D.
Publicado em 2017Texto -
20
Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma por Ribas, Antoni, Lawrence, Donald, Atkinson, Victoria, Agarwal, Sachin, Miller, Wilson H., Carlino, Matteo S., Fisher, Rosalie, Long, Georgina V., Hodi, F. Stephen, Tsoi, Jennifer, Grasso, Catherine S., Mookerjee, Bijoyesh, Zhao, Qing, Ghori, Razi, Moreno, Blanca Homet, Ibrahim, Nageatte, Hamid, Omid
Publicado em 2019Texto